Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362)): Polygenic risk modeling for prediction of epithelial ovarian cancer risk
- EMBRACE Collaborators
- , The CIMBA Consortium
- , AOCS Group
- , KConFab Investigators
- , AOCS Group
- , GEMO Study Collaborators
- , GEMO Study Collaborators
- , GC-HBOC Study Collaborators
- , OPAL Study Group
- , HEBON Investigators
- , The OCAC Consortium
- , GEMO Study Collaborators
- Netherlands Cancer Institute
- University of Cambridge
- Cedars-Sinai Medical Center
- Radboud University Nijmegen
- The Netherlands Comprehensive Cancer Organization (IKNL)
- Antoni van Leeuwenhoek Hospital
- IRCCS Istituto Oncologico Veneto - Padova
- University of Toronto
- University of California at Irvine
- N.N. Alexandrov Research Institute of Oncology and Medical Radiology
- ‘Agii Anargiri’ Cancer Hospital
- University of Texas MD Anderson Cancer Center
- Lund University
- Vall d'Hebron Institute of Oncology
- University Hospital Vall d’Hebron
- Rutgers - The State University of New Jersey, New Brunswick
- Landspitali University Hospital
- University of Iceland
- Friedrich-Alexander University Erlangen-Nürnberg
- Vanderbilt University
- Center for Biomedical Network Research on Rare Diseases (CIBERER)
- Biomedical Network on Rare Diseases (CIBERER)
- Russian Academy of Sciences
- Princess Margaret Cancer Centre
- University of Bergen
- National Institutes of Health
- Hannover Medical School
- IRCCS Istituto Europeo di Oncologia - Milano
- Cancer Research UK Cambridge Institute
- Maria Sklodowska-Curie Institute of Oncology
- University of Helsinki
- University of Utah
- University of Pisa
- University of Melbourne
- Peter Maccallum Cancer Centre
- Roswell Park Cancer Institute
- Ohio State University
- German Cancer Research Center
- University of Hamburg
- Tianjin Medical University
- Westmead Hospital
- University of Sydney
- Columbia University
- Ghent University
- Genetic Epidemiology of Cancer team
- Institut Curie
- École des mines Paris
- University of Cologne
- Leipzig University
- University of Southampton
- Cambridge
- University of New Mexico
- Alberta Health Services
- Mayo Clinic
- Memorial Sloan-Kettering Cancer Center
- Hospital Clínico San Carlos de Madrid
- NorthShore University HealthSystem
- University of Chicago
- Leiden University
- Oncogenetics Group
- City of Hope National Medical Center
- University of Pennsylvania
- Kliniken Essen-Mitte
- Dr. Horst Schmidt Klinik GmbH
- Friedrich Schiller University Jena
- Harvard University
- Brigham and Women's Hospital
- University of Manchester
- Manchester University NHS Foundation Trust
- University of California at Los Angeles
- Imperial College London
- Masaryk Memorial Cancer Institute
- Sheba Medical Center at Tel Hashomer
- Tel Aviv University
- Dana-Farber Cancer Institute
- University of Florence
- Cancer Council Victoria
- Centre for Epidemiology and Biostatistics
- Monash University
- University of Kansas
- Pomeranian Medical University in Szczecin
- University of Southern California
- Karolinska Institutet
- University of Copenhagen
- Fred Hutchinson Cancer Research Center
- University of Washington
- National University of Singapore
- MOH Holdings Pte Ltd.
- Humboldt University of Berlin
- Danish Cancer Society
- University of British Columbia
- Russian Ministry of Health
- Queensland Institute of Medical Research
- University of Groningen
- Georgetown University
- Vilnius University
- State Research Institute Centre for Innovative Medicine
- Stanford University
- Royal Marsden Hospital
- Seoul National University
- University of California at Davis
- Hollings Cancer Center
- St. Petersburg State University
- Sungkyunkwan University
- Cancer Genetics Centre
- The University of Hong Kong
- Hong Kong Sanatorium & Hospital
- Flanders Institute for Biotechnology
- KU Leuven
- Centro de Investigación Biomédica en Red de Cáncer
- British Columbia Cancer Agency
- New York University
- Agency for Science, Technology and Research, Singapore
- University of Pittsburgh
- Fondazione IRCCS Istituto Nazionale dei Tumori
- Duke University
- University of Hawai'i at Mānoa
- Aichi Cancer Center Hospital and Research Institute
- Nagoya University
- Public Health Ontario
- University of Glasgow
- University College London
- Oregon Health and Science University
- National Cancer Centre
- Lee Kong Chian School of Medicine
- University of Southern Denmark
- Latvian Biomedical Research and Study Centre
- National Institute of Oncology
- Aalborg University
- Instituto Português de Oncologia do Porto Francisco Gentil E.P.E.
- Moffitt Cancer Center
- FIRC Institute of Molecular Oncology
- Ufa University of Science and Technology
- Yale University
- Fundación Pública Galega Medicina Xenómica
- Instituto de Investigación Sanitaria de Santiago de Compostela
- Université Laval
- Hebei Medical University
- Icahn School of Medicine at Mount Sinai
- Medical University of Vienna
- Department of Clinical Pathology
- Royal Alexandra Hospital, Edmonton
- Université Paris Cité
- INSERM U830
- University of South Florida
- University of Porto
- Cancer Research Malaysia
- University of Malaya
- Emory University
- University of Michigan, Ann Arbor
- Uppsala University
- Dartmouth College
- Royal Pass Road
- Complejo Hospitalario Universitario de Santiago
- Beth Israel Deaconess Medical Center
- Universidad Javeriana
- McGill University
- University of Oxford
- University of Pretoria
- Demokritos National Centre for Scientific Research
- Charles University
- University of New South Wales
Research output: Contribution to journal › Comment/debate
3
Scopus
citations